Siegfried Holding AG is a leading global contract development and manufacturing organization (CDMO) specializing in the life sciences sector, with a primary focus on pharmaceuticals and biotechnology.... Siegfried Holding AG is a leading global contract development and manufacturing organization (CDMO) specializing in the life sciences sector, with a primary focus on pharmaceuticals and biotechnology. Founded in 1873 and headquartered in Zofingen, Switzerland, the company operates 13 production sites across three continents, serving over 500 clients worldwide. Siegfried provides integrated services that span the entire value chain, including process development, registration, production, packaging, and logistics for both active pharmaceutical ingredients (APIs) and finished dosage forms. Its offerings cover a broad spectrum, from custom synthesis and non-exclusive APIs for therapeutic areas such as anesthesia, pain management, and respiratory disorders, to sterile fill-and-finish, ophthalmics, inhalation devices, oral solid dosages, and viral vectors for gene therapy. Recognized for its commitment to innovation, quality, and sustainability, Siegfried supplies approximately 200 FDA-approved APIs and plays a vital role in ensuring safe pharmaceuticals reach patients globally. The company is notable for its contribution to industrial-scale production, evidenced by its involvement in manufacturing over 100 million Covid-19 vaccine doses, and its ongoing focus on greener, more efficient manufacturing processes.
Group Entities data not yet covered for Siegfried Holding
We have not yet reviewed Siegfried Holding's disclosures for Group Entities data.
If this data is relevant to your work, you can submit a data coverage request and our team
will investigate the company's disclosures and capture the data if available.